LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2 - Revision history

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-04-14T21:00:00Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision		Revision as of 06:00, 15 April 2010
(No difference)

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-02-25T10:00:10Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision	Revision as of 19:00, 25 February 2010
(No difference)

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-02-19T14:00:10Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision		Revision as of 23:00, 19 February 2010
Line 6:		Line 6:
	\|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&		\|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&
	\|Melting Point=ca. 270° <<0015>>		\|Melting Point=ca. 270° <<0015>>
	\|Reflactive=[alpha]_D = -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>		\|Reflactive=[ alpha ]_D = -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>
	\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>		\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>
	\|NMR Spectra=^1 H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,		\|NMR Spectra=^1 H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-02-19T14:00:00Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision		Revision as of 23:00, 19 February 2010
Line 6:		Line 6:
	\|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&		\|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&
	\|Melting Point=ca. 270° <<0015>>		\|Melting Point=ca. 270° <<0015>>
	\|Reflactive=[~~<FONT FACE="Symbol">a</FONT>~~]~~<SUB><FONT SIZE=-1>D</FONT></SUB>~~= -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>		\|Reflactive=[alpha]_D = -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>
	\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>		\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>
	\|NMR Spectra=~~<SUP><FONT SIZE=-~~1~~>1</FONT></SUP>~~H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,		\|NMR Spectra=^1 H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-02-18T15:00:00Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision		Revision as of 00:00, 19 February 2010
Line 4:		Line 4:
	\|LipidBank=PPA0026		\|LipidBank=PPA0026
	\|SysName=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine		\|SysName=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine
	\|Common Name=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine		\|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&
	\|Melting Point=ca. 270° 0015		\|Melting Point=ca. 270° <<0015>>
	\|Reflactive=[FONT FACE=~~Symbola~~/FONT]~~SUBFONT~~ SIZE=-1D/FONT/SUB= -0.78° (c=5, CHCl3/CH3OH 1:1) 0015		\|Reflactive=[<FONT FACE="Symbol">a</FONT>]<SUB><FONT SIZE=-1>D</FONT></SUB>= -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>
	\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). 0015		\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>
	\|NMR Spectra=~~SUPFONT~~ SIZE=-11/FONT/~~SUPH~~-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). 0015,		\|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-01-27T20:00:00Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision		Revision as of 05:00, 28 January 2010
Line 4:		Line 4:
	\|LipidBank=PPA0026		\|LipidBank=PPA0026
	\|SysName=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine		\|SysName=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine
	\|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&		\|Common Name=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine
	\|Melting Point=ca. 270° <<0015>>		\|Melting Point=ca. 270° 0015
	\|Reflactive=[<FONT FACE=~~"Symbol">a<~~/FONT>]~~<SUB><FONT~~ SIZE=-~~1>D<~~/FONT></SUB>= -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>		\|Reflactive=[FONT FACE=Symbola/FONT]SUBFONT SIZE=-1D/FONT/SUB= -0.78° (c=5, CHCl3/CH3OH 1:1) 0015
	\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>		\|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). 0015
	\|NMR Spectra=~~<SUP><FONT~~ SIZE=-~~1>1<~~/FONT></~~SUP>H~~-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,		\|NMR Spectra=SUPFONT SIZE=-11/FONT/SUPH-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). 0015,
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

Editor: LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

2010-01-20T01:39:06Z

LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001:02 moved to LBGPCkkp:18000SC01:YS1CA0002:YB2PHb001 2

← Older revision		Revision as of 10:39, 20 January 2010
(No difference)

Editor at 13:00, 26 July 2009

2009-07-26T13:00:00Z

← Older revision		Revision as of 22:00, 26 July 2009
Line 1:		Line 1:
			{{Lipid/Header}}

	{{Metabolite		{{Metabolite
	\|LipidBank=PPA0026		\|LipidBank=PPA0026
Line 8:		Line 10:
	\|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,		\|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,
	}}		}}

			{{Lipid/Footer}}

Editor at 12:00, 8 July 2009

2009-07-08T12:00:00Z

New page

{{Metabolite
|LipidBank=PPA0026
|SysName=1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine
|Common Name=&&1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine&&
|Melting Point=ca. 270° <<0015>>
|Reflactive=[a]D= -0.78° (c=5, CHCl3/CH3OH 1:1) <<0015>>
|IR Spectra=3480, 1630(OH, H2O); 1264 (P=O); 1104, 1070 (Ether); 1070 (P-O-). <<0015>>
|NMR Spectra=1H-NMR (80 MHz): 0.9(br. t, 3H, (CH2)16CH3); 1.27 (br. s, ca. 32 H, (CH2)16CH3); 3.40(s, 9H, N(CH3)3; 3.48 (s, 3H, OCH3); ca. 3.50-4.60 (m, ca 11H, 4 OCH2, CH2-N(CH3)3 and H-C(2). <<0015>>,
}}